House Appropriators' Report Tracks With FDA Concern About CBD Supplements
Executive Summary
House Appropriators expect FDA to assert commitment to identifying lawful regulatory pathways for CBD food and supplements if those pathways are consistent with protection of public health. Committee also expresses concern over proliferation of CBD supplements and foods in violation of FDA regulations.
You may also be interested in...
FDA Appropriation Targets $100,000 To Find Safe CBD Level In Supplements
Rep. McNerneny's amendment calls for process that would follow steps FDA used in exercising enforcement discretion on natural products that contain levels of an approved drug ingredient, with red yeast rice most notable. But critics of FDA's VMS industry oversight don't see McNerney's amendment as effective not only for strengthening FDA's overall regulation but also for solving its CBD problem.
FDA Cosmetics Funding ‘Inadequate’ – Appropriators Propose $4m Increase
Proposing $4m bump in FY 2020 for Office of Cosmetics and Colors, House appropriators are "concerned that FDA’s current authority and resources to oversee cosmetics and personal care products are inadequate to properly ensure the safety of cosmetics products.”
Acetaminophen Dose Labeling, More Sunscreen Information Needed, House Appropriators Tell FDA
Appropriators are "concerned that the lack of dosing information" on OTC drugs for children ages six months to 2 years "may lead to dosing errors, adverse events and inadequate treatment of fever and pain.” They also ask USDA about fraud in its National Organic Program.